oct 5, 2021

Sources for publishing:

Merck Announces Phase 3 Interim Analysis

Merck says COVID-19 pill cuts risk of death, hospitalization

New antiviral is highly effective study finds, and is stirring hope that COVID-19 could be treated by a pill

Click HERE for a good backgrounder on molnupiravir's backstory

HERE's a good explainer on how molnupiravir and other treatments work

Sign up today to

Get SmartHER News In Your Inbox

Read our Privacy Policy